To confirm these findings, we knocked down the expression of DR5 using specific siRNA against DR5 followed by combination treatment of sub-toxic doses of Resveratrol and TRAIL for 24 hours in DLBCL cells. This evidence concerns the gene TNFRSF10B and diffuse large B-cell lymphoma.